CCSC

National Hemophilia Foundation

Website provided by National Hemophilia Foundation and its education partners

Koffee Talk: Copay Accumulator Adjustment Programs

Part I: Copay Accumulator Adjust Programs (CAAPs) Overview

Part II: Employer Perspective on CAAPs

References
Patients & Family Caregivers: Prescription Drug Affordability Challenges During COVID-19
How CVS Health Drives McKesson’s Distribution Financials

Part III: Risks to the Patient

References
Building A Healthier Future For All: The 2020 Janssen U.S. Transparency Report
Impact of a Co-pay Accumulator Adjustment Program on Specialty Drug Adherence

Part IV: Patient Scenario

Part V: Summary

Part VI: NHF Survey Results

 

Jointly provided by

Jointly provided by

    

  • CCSC is supported by charitable donations from founding supporter Takeda, and additional support from Bayer AG, Pharmaceuticals, BioMarin, bluebird bio, Inc., CSL Behring, Genentech, Inc., Hemophilia Alliance, Novo Nordisk, Inc., Pfizer, Inc., Sanofi Genzyme, and Spark Therapeutics.

    © 2021 National Hemophilia Foundation. All rights reserved.

    Staff Log In

 

Footer Menu